These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31748968)

  • 21. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease.
    Uhlenberg B; Schuelke M; Rüschendorf F; Ruf N; Kaindl AM; Henneke M; Thiele H; Stoltenburg-Didinger G; Aksu F; Topaloğlu H; Nürnberg P; Hübner C; Weschke B; Gärtner J
    Am J Hum Genet; 2004 Aug; 75(2):251-60. PubMed ID: 15192806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple functions of the SNARE protein Snap29 in autophagy, endocytic, and exocytic trafficking during epithelial formation in Drosophila.
    Morelli E; Ginefra P; Mastrodonato V; Beznoussenko GV; Rusten TE; Bilder D; Stenmark H; Mironov AA; Vaccari T
    Autophagy; 2014; 10(12):2251-68. PubMed ID: 25551675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of GJC2 gene mutations in Chinese patients with Pelizaeus-Merzbacher-like disease.
    Ji T; Li D; Wu Y; Xiao J; Ji H; Wu X; Wang J; Jiang Y
    Minerva Pediatr (Torino); 2023 Feb; 75(1):32-38. PubMed ID: 27057822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma.
    Sprecher E; Ishida-Yamamoto A; Mizrahi-Koren M; Rapaport D; Goldsher D; Indelman M; Topaz O; Chefetz I; Keren H; O'brien TJ; Bercovich D; Shalev S; Geiger D; Bergman R; Horowitz M; Mandel H
    Am J Hum Genet; 2005 Aug; 77(2):242-51. PubMed ID: 15968592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease.
    Salviati L; Trevisson E; Baldoin MC; Toldo I; Sartori S; Calderone M; Tenconi R; Laverda A
    Neurogenetics; 2007 Jan; 8(1):57-60. PubMed ID: 17031678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype.
    Plecko B; Stöckler-Ipsiroglu S; Gruber S; Mlynarik V; Moser E; Simbrunner J; Ebner F; Bernert G; Harrer G; Gal A; Prayer D
    Neuropediatrics; 2003 Jun; 34(3):127-36. PubMed ID: 12910435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.
    Ashrafi MR; Amanat M; Garshasbi M; Kameli R; Nilipour Y; Heidari M; Rezaei Z; Tavasoli AR
    Expert Rev Neurother; 2020 Jan; 20(1):65-84. PubMed ID: 31829048
    [No Abstract]   [Full Text] [Related]  

  • 28. Promoter mutation is a common variant in GJC2-associated Pelizaeus-Merzbacher-like disease.
    Meyer E; Kurian MA; Morgan NV; McNeill A; Pasha S; Tee L; Younis R; Norman A; van der Knaap MS; Wassmer E; Trembath RC; Brueton L; Maher ER
    Mol Genet Metab; 2011 Dec; 104(4):637-43. PubMed ID: 21959080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
    Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
    Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A recurrent TMEM106B mutation in hypomyelinating leukodystrophy: A rapid diagnostic assay.
    Ikemoto S; Hamano SI; Kikuchi K; Koichihara R; Hirata Y; Matsuura R; Hiraide T; Nakashima M; Inoue K; Kurosawa K; Saitsu H
    Brain Dev; 2020 Sep; 42(8):603-606. PubMed ID: 32595021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NEK3-mediated SNAP29 phosphorylation modulates its membrane association and SNARE fusion dependent processes.
    Rapaport D; Fichtman B; Weidberg H; Sprecher E; Horowitz M
    Biochem Biophys Res Commun; 2018 Mar; 497(2):605-611. PubMed ID: 29454964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of cerebral hypomyelination with spondylo-epi-metaphyseal dysplasia.
    Kimura-Ohba S; Kagitani-Shimono K; Hashimoto N; Nabatame S; Okinaga T; Murakami A; Miyake N; Matsumoto N; Osaka H; Hojo K; Tomita R; Taniike M; Ozono K
    Am J Med Genet A; 2013 Jan; 161A(1):203-7. PubMed ID: 23239615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Snapshots from within the cell: Novel trafficking and non trafficking functions of Snap29 during tissue morphogenesis.
    Smeele PH; Vaccari T
    Semin Cell Dev Biol; 2023 Jan; 133():42-52. PubMed ID: 35256275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.
    Nafisinia M; Sobreira N; Riley L; Gold W; Uhlenberg B; Weiß C; Boehm C; Prelog K; Ouvrier R; Christodoulou J
    Eur J Hum Genet; 2017 Oct; 25(10):1134-1141. PubMed ID: 28905880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased level of N-acetylaspartylglutamate (NAAG) in the CSF of a patient with Pelizaeus-Merzbacher-like disease due to mutation in the GJA12 gene.
    Sartori S; Burlina AB; Salviati L; Trevisson E; Toldo I; Laverda AM; Burlina AP
    Eur J Paediatr Neurol; 2008 Jul; 12(4):348-50. PubMed ID: 17881259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pelizaeus-Merzbacher disease, easily misdiagnosed as cerebral palsy: a report of a three-generation family.
    Chen YC; Liang WC; Su YN; Jong YJ
    Pediatr Neonatol; 2014 Apr; 55(2):150-3. PubMed ID: 23597542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurogenetics of Pelizaeus-Merzbacher disease.
    Osório MJ; Goldman SA
    Handb Clin Neurol; 2018; 148():701-722. PubMed ID: 29478609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients.
    Ji H; Li D; Wu Y; Zhang Q; Gu Q; Xie H; Ji T; Wang H; Zhao L; Zhao H; Yang Y; Feng H; Xiong H; Ji J; Yang Z; Kou L; Li M; Bao X; Chang X; Zhang Y; Li L; Li H; Niu Z; Wu X; Xiao J; Jiang Y; Wang J
    PLoS One; 2018; 13(2):e0188869. PubMed ID: 29451896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular confirmation of founder mutation c.-167A>G in Tunisian patients with PMLD disease.
    Kammoun Jellouli N; Salem IH; Ellouz E; Louhichi N; tlili A; Kammoun F; Triki C; Fakhfakh F;
    Gene; 2013 Jan; 513(2):233-8. PubMed ID: 23142375
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.